Odyssey Group International Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 3
Employees
  • Stock Symbol
  • ODYY
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $0.33
  • (As of Thursday Closing)

Odyssey Group International General Information

Description

Odyssey Group International Inc is a trans-disciplinary product development enterprise involved in the discovery, development and commercialization of a broad range of products. It provides athletic enhancement products to improve the human body's function during athletic stress. The company also owns technology and the marketing and distribution rights to CardioMap. The company's revenue is mainly derived from product sales of a health supplement product called Fit and a heart scanning technology called CardioMap.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Capital Markets/Institutions
Stock Exchange
PINX
Primary Office
  • 2372 Morse Avenue
  • Irvine, CA 92614
  • United States
+1 (619) 000-0000

Odyssey Group International Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Odyssey Group International Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.33 $0.31 $0.10 - $2.00 $25.4M 81.9M 49.4K -$0.17

Odyssey Group International Financials Summary

In Thousands,
USD
TTM 30-Apr-2021 FY 2020 31-Jul-2020 FY 2019 31-Jul-2019 FY 2018 31-Jul-2018
EV 81,194 33,879 121,019 192,309
Revenue 0 0 0 0
EBITDA (14,804) (3,836) (23,348) (410)
Net Income (15,315) (4,349) (23,429) (483)
Total Assets 1,454 106 536 27
Total Debt 676 276 785 632
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Odyssey Group International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Odyssey Group International‘s full profile, request access.

Request a free trial

Odyssey Group International Executive Team (2)

Name Title Board Seat Contact Info
Michael Redmond President, Chief Executive Officer & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Odyssey Group International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Odyssey Group International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Odyssey Group International‘s full profile, request access.

Request a free trial

Odyssey Group International Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00000000 02-Mar-2021 000000000 00000 00 Buildings and Property
00000 0000000 (000 27-Jun-2019 00000 0000000 Biotechnology
Well-Med Global 13-Jan-2014 Merger of Equals Pharmaceuticals
To view Odyssey Group International’s complete investments and acquisitions history, request access »